Therefore, it is important for future work to validate this methodology on whole tissue biopsies or resected tumour block sections immunostained for MLH1, as these samples are currently used for diagnostic assessment and reporting in pathology laboratories. This evidence concerns the gene MLH1 and neoplasm.